Domo signs strategic collaboration agreement with AWS for AI solutions
David Linetsky, Senior Vice President of Life Sciences at Phreesia, Inc. (NYSE:PHR), a healthcare technology company with a market capitalization of $1.4 billion and strong revenue growth of ~18% year-over-year, recently sold shares in the company totaling $99,990. According to InvestingPro analysis, PHR currently appears undervalued despite maintaining moderate debt levels and showing promising growth prospects. The transactions, which took place on April 8, involved multiple sales of common stock at prices ranging from $23.4568 to $24.475 per share.
Linetsky disposed of 2,410 shares at a weighted average price of $23.4568, and an additional 1,534 shares at an average of $24.475. These transactions were conducted as part of a mandatory sell-to-cover policy to manage tax withholding obligations related to the settlement of restricted stock units. Following these transactions, Linetsky retains direct ownership of 221,738 shares and indirect ownership of 9,012 shares through his spouse.
In other recent news, Phreesia Inc . has been the subject of multiple analyst evaluations following its fourth-quarter fiscal year 2025 results. DA Davidson reiterated a Buy rating with a $36.00 price target, citing Phreesia's undervalued stock compared to its peers and highlighting its strategic approach in the U.S. healthcare services sector. Jefferies also raised Phreesia's price target from $28.00 to $32.00, maintaining a Buy rating based on the company's operational leverage and growth prospects in Network Solutions. KeyBanc Capital Markets maintained an Overweight rating with a $30.00 target, noting significant margin improvement and strong top-line growth. Raymond (NSE:RYMD) James held its Outperform rating with a $30.00 target, focusing on Phreesia's evolving narrative towards free cash flow and the strategic balance between growth and profitability. These recent developments underscore the analysts' confidence in Phreesia's future growth trajectory and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.